# Treatment of Secondary Hyperparathyroidism in the Uremic Patient

> **NCT00469599** · NA · TERMINATED · sponsor: **Zealand University Hospital** · enrollment: 86 (actual)

## Conditions studied

- Secondary Hyperparathyroidism
- Chronic Kidney Disease
- Vitamin D Deficiency

## Interventions

- **DRUG:** paricalcitol
- **DRUG:** alfacalcidol

## Key facts

- **NCT ID:** NCT00469599
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-10
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** Terminated after 86 pt included, because of recruitment problems
- **Last updated:** 2011-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469599, "Treatment of Secondary Hyperparathyroidism in the Uremic Patient". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00469599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*